title: Cerebrotendinous xanthomatosis: a treatable disease with juvenile cataracts as a presenting sign.
authors.affiliation: Casey Eye Institute, Portland, OR, USA.
authors.forename: Dinelli M
authors.initials: DM
authors.lastname: Monson
authors.forename: Andrea E
authors.initials: AE
authors.lastname: DeBarber
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Bock
authors.forename: George
authors.initials: G
authors.lastname: Anadiotis
authors.forename: Louise S
authors.initials: LS
authors.lastname: Merkens
authors.forename: Robert D
authors.initials: RD
authors.lastname: Steiner
authors.forename: Ann U
authors.initials: AU
authors.lastname: Stout
mesh_terms: D002386:Cataract / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D002387:Cataract Extraction; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use; D002648:Child; D004083:Cholestanol / Q000097:blood; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D014792:Visual Acuity / Q000502:physiology; D019294:Xanthomatosis, Cerebrotendinous / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D002635:Chenodeoxycholic Acid; D004083:Cholestanol